VJHemOnc is committed to improving our service to you

ESH AL 2020 | Challenges of CAR T-cell treatment in pediatric ALL

VJHemOnc is committed to improving our service to you

Christina Peters

Christina Peters, MD, St. Anna Children’s Hospital, Vienna, Austria, discusses the drawbacks and challenges that we must overcome in CAR T-cell treatment in pediatric cases of acute lymphoblastic leukemia (ALL). Complications can include inability to collect enough lymphocytes and potential viral infections. In addition, Dr Peters discusses the success rate of the treatment and importance of monitoring the patient’s progress once in remission. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter